chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: F
Vaccine: PPV, VARZOS
Symptoms: Erythema, Pain, Rash macular, Vaccination complication
Clinical narrative: Pt received both ZOSTAVAX (without diluent) and PNEUMOVAX in one syringe as a single dose. Pt returned Sun (5/23/10) with a softball sized reaction with symptoms of only soreness & erythema. Pt returned again on Mon (5/24) with whole side of arm with erythema & no other symptoms on Tues. (5/25). Pt arm was only splotchy.
Age: 37.0
Sex: M
Vaccine: HEPA, HEPA
Symptoms: Alanine aminotransferase increased, Arthralgia, Aspartate aminotransferase increased, Back pain, Chills
Clinical narrative: High fever, severe back pain, chills & sweats, headache, weight loss.
Age: 37.0
Sex: M
Vaccine: HEPA, HEPA
Symptoms: Myalgia, Pyrexia
Clinical narrative: High fever, severe back pain, chills & sweats, headache, weight loss.
Age: 37.0
Sex: M
Vaccine: HEPA, HEPA
Symptoms: Alanine aminotransferase, Aspartate aminotransferase, Back pain, Chills, Differential white blood cell count
Clinical narrative: High fever, severe back pain, chills & sweats, headache, weight loss.
Age: 37.0
Sex: M
Vaccine: HEPA, HEPA
Symptoms: Full blood count, Headache, Hyperhidrosis, Pyrexia, Urine analysis
Clinical narrative: High fever, severe back pain, chills & sweats, headache, weight loss.
Age: 37.0
Sex: M
Vaccine: HEPA, HEPA
Symptoms: Weight decreased
Clinical narrative: High fever, severe back pain, chills & sweats, headache, weight loss.
Age: 28.0
Sex: F
Vaccine: HEPA, PPV
Symptoms: Injection site erythema, Injection site rash, Injection site swelling, Injection site warmth, Oropharyngeal pain
Clinical narrative: On right arm: red rash/welts & swelling at injection site, skin at injection site warm to touch, feeling groggy, itchy sore throat.
Age: 28.0
Sex: F
Vaccine: HEPA, PPV
Symptoms: Somnolence, Throat irritation, Urticaria
Clinical narrative: On right arm: red rash/welts & swelling at injection site, skin at injection site warm to touch, feeling groggy, itchy sore throat.
Age: 1.7
Sex: F
Vaccine: FLU3, HEPA, PNC13
Symptoms: Erythema, Pain, Pruritus, Swelling, Urticaria
Clinical narrative: Redness, swelling, itching & pain developed within a few hours. The next day she developed worsening of generalized urticaria which had been very mild prior to receiving immunizations. HYDROXYZINE prescribed for urticaria on 5/20/10.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Redness and swelling, very minor itching at injection site.
Age: 11.0
Sex: M
Vaccine: HEPA, MNQ, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site haematoma, Injection site induration, Injection site warmth
Clinical narrative: Pt had on left upper arm a small bruise then the entire bicep was red, hard and hot to the touch.
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Computerised tomogram normal, Convulsion, Dizziness, Fall, Laboratory test normal
Clinical narrative: Pt had a dizzy spell, fell down and about 20-30 sec later had a seizure involving all extremities and twitching of mouth and eyes lasted for approx 1-2-min. Pt was transferred to ER. CT scan / labs - normal. Discharged.
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Muscle twitching
Clinical narrative: Pt had a dizzy spell, fell down and about 20-30 sec later had a seizure involving all extremities and twitching of mouth and eyes lasted for approx 1-2-min. Pt was transferred to ER. CT scan / labs - normal. Discharged.
Age: 38.0
Sex: M
Vaccine: ANTH
Symptoms: Abdominal pain upper, Arthralgia, Headache, Heart rate increased, Malaise
Clinical narrative: Malaise, start of fever, some nausea.  Progressed to 101.5 fever, rapid heart beat, aching joints stomach cramps and headache lasting until afternoon the following day.
Age: 38.0
Sex: M
Vaccine: ANTH
Symptoms: Nausea, Pyrexia
Clinical narrative: Malaise, start of fever, some nausea.  Progressed to 101.5 fever, rapid heart beat, aching joints stomach cramps and headache lasting until afternoon the following day.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Redness and swelling at site of injection -> lead to hospitalization for cellulitis.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, PNC13, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth, Pyrexia
Clinical narrative: Child febrile (temp unknown) per parent report on 5/20/10, arms painful to touch, child brought to health department on 5/21/10--afebrile at the time, bilateral arms red, swollen and warm to touch, child playing and acting appropriate.
Age: 1.25
Sex: M
Vaccine: DTAP, MMR
Symptoms: Decreased appetite, Fatigue, Pyrexia, Rash, Somnolence
Clinical narrative: Fever started the evening of 5/21/10, 99 degrees, but on 5/22/10, temp reached 105 degrees. Tired, sleepy, poor appetite. Rash developed 5/25/10.
Age: 3.0
Sex: M
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site induration, Injection site swelling
Clinical narrative: Left arm swelling, erythema, and induration to 8.5x9 cm.
Age: 0.5
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC, RV5
Symptoms: Pyrexia
Clinical narrative: Fever T-103 evening following vaccination.
Age: 76.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Non-Hodgkin's lymphoma
Clinical narrative: Information has been received from a consumer's wife concerning his husband, a 77 year old male patient with cancer and chemotherapy since 01-APR-2009 who on 12-MAY-2008 was vaccinated with a dose of ZOSTAVAX (Merck) (dose, route and lot number not reported). Concomitant therapy included doxorubicin and cyclophosphamide. The caller stated that on 25-JAN-2010 her husband developed shingles; she believed it was less effective because of the chemo. The patient sought for unspecified medical attention. Follow up information has been received which indicated that the patient received immunization at his county's Health Department and there was no doctor involved. In March 2009 the patient was diagnosed with Non-Hodgkin's Lymphoma. On 01-APR-2009 he began chemotherapy. The patient's last chemotherapy was on 22-JUL-2009. It was reported that recovery was going well. In January 2010 the patient came down with shingles. They had been told that chemotherapy, at times, could take immunity away. Upon internal review, "diagnosed with Non-Hodgkin's Lymphoma" was considered to be an other important medical event. Additional information has been requested.
Age: 1.26
Sex: F
Vaccine: DTAP, HIBV, PNC13
Symptoms: Injection site pain, Injection site vesicles, Pyrexia
Clinical narrative: Patient's mother arrived at the Health Department on 5/27/2010 to question the patient's blistered area on the left upper leg.  The area was the size of a quarter. The mother stated the child had a low grade fever and the leg was very sore.
Age: 0.35
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Crying, Erythema multiforme, Urticaria
Clinical narrative: 1) Uncontrolled crying lasting 6 hrs within 24 hrs of vaccinations. 2) Hives all over the body (erythema multiforme) lasting 1 week (no other cause).
Age: 1.14
Sex: F
Vaccine: DTAPIPVHIB, MMR, PNC, VARCEL
Symptoms: Blood culture negative, Chest X-ray normal, Culture urine negative, Febrile convulsion, Vaccination complication
Clinical narrative: Pt admitted to hospital for presumed febrile seizure secondary to reaction to immunization.
Age: 30.0
Sex: M
Vaccine: HEP
Symptoms: Oedema peripheral, Swelling face, Urticaria
Clinical narrative: Approx. 35 hours after admin of vaccine, client states he had developed hives and swelling over this arms and face, he stated he took BENADRYL and IB and these symptoms resolved. He did not seek any medical attention. No difficulty breathing or SOB.
Age: 7.0
Sex: M
Vaccine: HEPA, PNC13
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: At site of Hep A injection - red area approx 10cm in diameter noted at injection site (L thigh) area warm to touch noted on ED record.
Age: 33.0
Sex: M
Vaccine: HEP
Symptoms: Neuritis
Clinical narrative: VII cranial nerve - neuritis.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, HIBV, MMR, VARCEL
Symptoms: Erythema, Oedema peripheral, Skin warm
Clinical narrative: Mother states that patient's left arm is swollen and red; it feels warm to touch.
Age: 12.0
Sex: F
Vaccine: HPV4, HEPA, HPV4, HPV4
Symptoms: Headache, Nuclear magnetic resonance imaging
Clinical narrative: Headaches after 1st GARDASIL shot.
Age: 12.0
Sex: F
Vaccine: HPV4, HEPA, HPV4, HPV4
Symptoms: Headache
Clinical narrative: Headaches after 1st GARDASIL shot.
Age: 12.0
Sex: F
Vaccine: HPV4, HEPA, HPV4, HPV4
Symptoms: Brain neoplasm, Headache, Nuclear magnetic resonance imaging
Clinical narrative: Headaches after 1st GARDASIL shot.
Age: 14.0
Sex: F
Vaccine: HPV4
Symptoms: Fall, Pallor
Clinical narrative: Mom called from the room for help.  When we came in the pt had fallen from the bed to the floor.  She was pale.  We rolled her over and woke her back up.  Lifted her feet and gave her cold water and a sucker.  She layed on the floor for about 5-10 minutes.  Dr. looked her over and said she looked fine.
Age: 52.0
Sex: M
Vaccine: FLUX, IPV, MMR, TD, FLU3, IPV, MMR, TTOX
Symptoms: Urticaria
Clinical narrative: Hives over legs, arms, torso.
Age: 41.0
Sex: F
Vaccine: VARCEL
Symptoms: Back pain, Body temperature increased, Liver function test abnormal, Pharyngitis, Pleuritic pain
Clinical narrative: Information has been received from a physician concerning a 41 year old female patient who on approximately 01-MAY-2010 was vaccinated with a first dose of VARIVAX (Merck) (Lot # not provided). It was reported that the patient experienced multiple symptoms since receiving VARIVAX (Merck). The adverse event began as low back pain and 1 week later she developed right scapula radiculitis. She also developed a fever of 101F that lasted 1 or 2 days. She also had pharyngitis. She was admitted to the hospital and then discharged on antibiotics. After discharge she developed pleuritic chest pain and was admitted to another hospital. She also had slightly elevated liver enzymes. At the time of this report, the patient had not recovered. The adverse events were considered to be other important medical events by the physician. Additional information has been requested.
Age: 41.0
Sex: F
Vaccine: VARCEL
Symptoms: Pyrexia, Radiculitis
Clinical narrative: Information has been received from a physician concerning a 41 year old female patient who on approximately 01-MAY-2010 was vaccinated with a first dose of VARIVAX (Merck) (Lot # not provided). It was reported that the patient experienced multiple symptoms since receiving VARIVAX (Merck). The adverse event began as low back pain and 1 week later she developed right scapula radiculitis. She also developed a fever of 101F that lasted 1 or 2 days. She also had pharyngitis. She was admitted to the hospital and then discharged on antibiotics. After discharge she developed pleuritic chest pain and was admitted to another hospital. She also had slightly elevated liver enzymes. At the time of this report, the patient had not recovered. The adverse events were considered to be other important medical events by the physician. Additional information has been requested.
Age: 26.0
Sex: F
Vaccine: JEV1, MNQ
Symptoms: Paraesthesia
Clinical narrative: Tingling (pins and needles sensation--no pain) in left forearm and left hand intermittently still on 5/25/2010.  Encouraged to MD if symptom continues
Age: 9.0
Sex: F
Vaccine: HEPA, VARCEL, HEPA, VARCEL
Symptoms: Catatonia, Cyanosis, Hypotension, Pallor, Pruritus
Clinical narrative: Paying co-pay at window, patient became extremely pale, blue lips, catatonic, said, "throat hurts".  Nurse took her back to treatment room where she was laid down, knees elevated, bp checked (extremely low).  Sat up, given Gatorade.  Checked bp x2, color returned to face and lips.  Left building.  Fifteen minutes later returned patient to facility with large, raised, itchy welts/hives extending out from the injection site.  Patient was administered Benadryl and monitored for approximately 45 minutes.  One day after event patient continue to complaining of itching but with reduced hives.
Age: 9.0
Sex: F
Vaccine: HEPA, VARCEL, HEPA, VARCEL
Symptoms: Throat irritation, Urticaria
Clinical narrative: Paying co-pay at window, patient became extremely pale, blue lips, catatonic, said, "throat hurts".  Nurse took her back to treatment room where she was laid down, knees elevated, bp checked (extremely low).  Sat up, given Gatorade.  Checked bp x2, color returned to face and lips.  Left building.  Fifteen minutes later returned patient to facility with large, raised, itchy welts/hives extending out from the injection site.  Patient was administered Benadryl and monitored for approximately 45 minutes.  One day after event patient continue to complaining of itching but with reduced hives.
Age: 9.0
Sex: F
Vaccine: HEPA, VARCEL, HEPA, VARCEL
Symptoms: Pruritus, Urticaria
Clinical narrative: Paying co-pay at window, patient became extremely pale, blue lips, catatonic, said, "throat hurts".  Nurse took her back to treatment room where she was laid down, knees elevated, bp checked (extremely low).  Sat up, given Gatorade.  Checked bp x2, color returned to face and lips.  Left building.  Fifteen minutes later returned patient to facility with large, raised, itchy welts/hives extending out from the injection site.  Patient was administered Benadryl and monitored for approximately 45 minutes.  One day after event patient continue to complaining of itching but with reduced hives.
Age: 9.0
Sex: F
Vaccine: HEPA, VARCEL, HEPA, VARCEL
Symptoms: Catatonia, Cyanosis, Hypotension, Pallor, Pruritus
Clinical narrative: Pt returned to office @ 1045 with hives on back and ( R ) shoulder. Complaining of ( R ) arm itching. Gave 2 tsp BENADRYL BP 90/62. No breathing problems. 1120 Hives resolving. No swallowing or breathing difficulties. Pt released to home. Advised by RN to give BENADRYL q 6-8 hours prn. If sx return or worsen mom to call 911.
Age: 9.0
Sex: F
Vaccine: HEPA, VARCEL, HEPA, VARCEL
Symptoms: Throat irritation, Urticaria
Clinical narrative: Pt returned to office @ 1045 with hives on back and ( R ) shoulder. Complaining of ( R ) arm itching. Gave 2 tsp BENADRYL BP 90/62. No breathing problems. 1120 Hives resolving. No swallowing or breathing difficulties. Pt released to home. Advised by RN to give BENADRYL q 6-8 hours prn. If sx return or worsen mom to call 911.
Age: 9.0
Sex: F
Vaccine: HEPA, VARCEL, HEPA, VARCEL
Symptoms: Pruritus, Urticaria
Clinical narrative: Pt returned to office @ 1045 with hives on back and ( R ) shoulder. Complaining of ( R ) arm itching. Gave 2 tsp BENADRYL BP 90/62. No breathing problems. 1120 Hives resolving. No swallowing or breathing difficulties. Pt released to home. Advised by RN to give BENADRYL q 6-8 hours prn. If sx return or worsen mom to call 911.
Age: 4.0
Sex: F
Vaccine: PNC13
Symptoms: Erythema, Pruritus, Swelling
Clinical narrative: Initial just a small area of redness and swelling the day after injection, followed by increasing redness and itching and swelling.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMRV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Woke up swelling and redness to left arm. Used cold compress. No fever. Redness and swelling increasing in size. Area measures 5 x 8 cm.
Age: 2.0
Sex: F
Vaccine: DTAPIPVHIB, HEP
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: LEFT THIGH WITH SLIGHTLY RAISED ERYTHEMATOUS PATCH APPROX. 3X4CM; NO WARMTH, NO PAIN WITH PALPATION; (+) PRURITIS.
Age: 55.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Erythema, Lip pain, Lip swelling, Rash erythematous, Rash generalised
Clinical narrative: Red bumps all over body - lips red/tender/swollen.
Age: 11.0
Sex: M
Vaccine: HEPA, MNQ, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: Localized induration and erythema on RA - Hep. A and VARIVAX. Diameter of 2in. warm compress TID and IB. May last for 1 wk.
Age: 11.0
Sex: F
Vaccine: HEPA, HPV2, MNQ, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: Localized induration and erythema on rt arm - HPV and VAR. Diameter of 2in. Warm compress 20min TID and IB. May last for 1wk.
Age: 9.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, HPV4
Symptoms: Blood glucose normal, Syncope
Clinical narrative: 5 to 10 minutes after receiving 3 injections pt became faint. Glucose level 80. Administered 4 oz fruit juice. VS WNL. Patient fully recovered 10 -15 minutes post administration.
Age: 9.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, HPV4
Symptoms: Presyncope
Clinical narrative: 5 to 10 minutes after receiving 3 injections pt became faint. Glucose level 80. Administered 4 oz fruit juice. VS WNL. Patient fully recovered 10 -15 minutes post administration.
Age: 12.0
Sex: F
Vaccine: HEPA, HPV4, TDAP, HPV4
Symptoms: Chest X-ray normal, Electrocardiogram abnormal, Left ventricular hypertrophy, Syncope
Clinical narrative: Patient waited in room for 15-20 min. Asymptomatic @ that time mom and patient walked to check out patient became faint. Returned to room for re-eval/monitoring.
Age: 12.0
Sex: F
Vaccine: HEPA, HPV4, TDAP, HPV4
Symptoms: Loss of consciousness, Presyncope
Clinical narrative: Patient waited in room for 15-20 min. Asymptomatic @ that time mom and patient walked to check out patient became faint. Returned to room for re-eval/monitoring.
Age: 13.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Right arm aspect red, swollen.
Age: 47.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site haematoma, Injection site pain, Injection site swelling, Pain
Clinical narrative: The evening of injection she had some redness and tender at injection site. She noticed the redness spreading from injection site around her arm and down to elbow. She said the redness turned purple color, swollen, and painful to move. The reaction resolved after 6-7 days.
Age: 0.76
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13
Symptoms: Grand mal convulsion, Immediate post-injection reaction, Oxygen saturation normal, Pallor, Postictal state
Clinical narrative: Right after vaccines - became pale, developed tonic clonic sz lasting about 3 min. Heart rate normal O2 Sats nl. Postictal period after about 20-30 min.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: 10cm by 4cm swollen red on Rt arm where DTaP was given.
Age: 9.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site nodule, Injection site pruritus, Injection site warmth
Clinical narrative: Pt c/o itching, redness, warmth with hard knot & tingling to back of upper rt arm where VZV administered yesterday. Referred to Care Center for eval ASAP.
Age: 9.0
Sex: F
Vaccine: VARCEL
Symptoms: Paraesthesia
Clinical narrative: Pt c/o itching, redness, warmth with hard knot & tingling to back of upper rt arm where VZV administered yesterday. Referred to Care Center for eval ASAP.
Age: 1.0
Sex: M
Vaccine: HEPA, MMR, PNC13, VARCEL
Symptoms: Chest X-ray normal, Computerised tomogram normal, Convulsion, Culture urine negative, Electroencephalogram normal
Clinical narrative: Seizure on 5/20/10 at daycare.
Age: 1.0
Sex: M
Vaccine: HEPA, MMR, PNC13, VARCEL
Symptoms: Full blood count, Laboratory test, Urine analysis
Clinical narrative: Seizure on 5/20/10 at daycare.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site induration, Injection site rash, Injection site swelling, Injection site urticaria
Clinical narrative: Vaccine administered 5-27-10. Pt woke up next morning with swollen arm at site. Dr assessed 1 1/2" indurated urticarial on right triceps non-tender - rash secondary to VARIVAX.
Age: 5.0
Sex: M
Vaccine: DTAPIPV, HEPA, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Bilateral swelling on upper arms, with redness and pain with touch. Resolved by 5-28-10.
Age: 15.0
Sex: F
Vaccine: MNQ
Symptoms: Asthenia, Dizziness, Fatigue, Headache, Pain
Clinical narrative: Patient is a 15 year old female who comes in today because of syncope, weakness, headache, and diffuse body pains. She was seen yesterday for routine physical. She complained then of having lots of fatigue. She received a MENACTRA vaccine and was sent to the lab for a blood draw. She had a brief syncopal episode after the blood draw. Today she felt weak and somewhat achey when she got up this morning. She tried to go to work but felt even more weak "as if she couldn't lift her arms or bear weight on her legs" and then had another episode of feeling faint and had to sit down to abort it. Since then she says her head, back and limbs are all hurting (to the point of tears). She has not had a fever. She has had blood work done in the past and never had a syncopal episode. She does not think that these symptoms are due to a panic attack.
Age: 15.0
Sex: F
Vaccine: MNQ
Symptoms: Syncope
Clinical narrative: Patient is a 15 year old female who comes in today because of syncope, weakness, headache, and diffuse body pains. She was seen yesterday for routine physical. She complained then of having lots of fatigue. She received a MENACTRA vaccine and was sent to the lab for a blood draw. She had a brief syncopal episode after the blood draw. Today she felt weak and somewhat achey when she got up this morning. She tried to go to work but felt even more weak "as if she couldn't lift her arms or bear weight on her legs" and then had another episode of feeling faint and had to sit down to abort it. Since then she says her head, back and limbs are all hurting (to the point of tears). She has not had a fever. She has had blood work done in the past and never had a syncopal episode. She does not think that these symptoms are due to a panic attack.
Age: 52.0
Sex: M
Vaccine: TDAP
Symptoms: Asthenia, Chills, Hyperhidrosis, Malaise, Migraine
Clinical narrative: Severe malaise, chills, sweats, weakness through the night. Next day was very weak. This precipitated a migraine. After about 36 hours, symptoms abated.
Age: 33.0
Sex: F
Vaccine: PPV
Symptoms: Back pain, Body temperature increased, Erythema, Headache, Heart rate irregular
Clinical narrative: Received vaccination at 11am on 5/26/2010.  At 5AM on 5/27/2010, woke up with temperature of 103.5F, achy all over, especially head, neck and back. C/O heart racing, irregular heart rate. States left arm swollen and sore at injection site,  Was seen at a clinic.  States was told to take Tylenol and Advil intermittently. States was told she was experiencing reactions from immunization received on 5/26/2010.  Was also told to take Benadryl.  States the evening of 5/27/2010 Went to ER because HA and Back pain, and fever of 103.5 continued.  On 5/28/2010 C/O of rash approx. 7" long on arm near injection site and "wraps around arm."  "Rash blotchy, dark and light red, purple, raised and hot to touch."
Age: 33.0
Sex: F
Vaccine: PPV
Symptoms: Injection site pain, Injection site swelling, Neck pain, Pain, Palpitations
Clinical narrative: Received vaccination at 11am on 5/26/2010.  At 5AM on 5/27/2010, woke up with temperature of 103.5F, achy all over, especially head, neck and back. C/O heart racing, irregular heart rate. States left arm swollen and sore at injection site,  Was seen at a clinic.  States was told to take Tylenol and Advil intermittently. States was told she was experiencing reactions from immunization received on 5/26/2010.  Was also told to take Benadryl.  States the evening of 5/27/2010 Went to ER because HA and Back pain, and fever of 103.5 continued.  On 5/28/2010 C/O of rash approx. 7" long on arm near injection site and "wraps around arm."  "Rash blotchy, dark and light red, purple, raised and hot to touch."
Age: 33.0
Sex: F
Vaccine: PPV
Symptoms: Rash, Skin warm, White blood cell count increased
Clinical narrative: Received vaccination at 11am on 5/26/2010.  At 5AM on 5/27/2010, woke up with temperature of 103.5F, achy all over, especially head, neck and back. C/O heart racing, irregular heart rate. States left arm swollen and sore at injection site,  Was seen at a clinic.  States was told to take Tylenol and Advil intermittently. States was told she was experiencing reactions from immunization received on 5/26/2010.  Was also told to take Benadryl.  States the evening of 5/27/2010 Went to ER because HA and Back pain, and fever of 103.5 continued.  On 5/28/2010 C/O of rash approx. 7" long on arm near injection site and "wraps around arm."  "Rash blotchy, dark and light red, purple, raised and hot to touch."
Age: 50.0
Sex: M
Vaccine: FLU3
Symptoms: Balance disorder, Fall, Laboratory test, Muscular weakness, Paraesthesia
Clinical narrative: Loss of balance, falling. Weakness in limbs.  Pins and needles in limbs.
Age: 65.0
Sex: F
Vaccine: TDAP
Symptoms: Rash erythematous, Rash pruritic
Clinical narrative: Itchy red rash on the left arm.  Treated with Benadryl.  Getting a little better.
Age: 25.0
Sex: M
Vaccine: TDAP
Symptoms: Arthralgia, Blood test, C-reactive protein, Chills, Complement factor C3
Clinical narrative: On 5/21/2010:  Complaints of nausea & vomiting, chills myalgias, arthralgias, fever of 103.8. 5/22/2010:  Pt comes to Urgent Care.  Pt was admitted for observation, meds and labs.  Intravenous Fluids, Intravenous Torodol, Intravenous Benadryl and Intravenous Steroids.
Age: 25.0
Sex: M
Vaccine: TDAP
Symptoms: Complement factor C4, Culture urine, Full blood count, Metabolic function test, Myalgia
Clinical narrative: On 5/21/2010:  Complaints of nausea & vomiting, chills myalgias, arthralgias, fever of 103.8. 5/22/2010:  Pt comes to Urgent Care.  Pt was admitted for observation, meds and labs.  Intravenous Fluids, Intravenous Torodol, Intravenous Benadryl and Intravenous Steroids.
Age: 25.0
Sex: M
Vaccine: TDAP
Symptoms: Nausea, Pyrexia, Red blood cell sedimentation rate, Urine analysis, Vomiting
Clinical narrative: On 5/21/2010:  Complaints of nausea & vomiting, chills myalgias, arthralgias, fever of 103.8. 5/22/2010:  Pt comes to Urgent Care.  Pt was admitted for observation, meds and labs.  Intravenous Fluids, Intravenous Torodol, Intravenous Benadryl and Intravenous Steroids.
Age: 65.0
Sex: F
Vaccine: PPV, TD
Symptoms: Rash generalised, Vaccination complication
Clinical narrative: Had Tetanus and Pneumonia vaccine on 5/25/2010 and on 5/27/2010 woke up with rash on neck and by midmorning rash had spread all over torso.  Called doctor's office and was told I probably had a reaction to the shots and to use Benadryl and Hydrocortisone cream.  Per doctor, rash would probably take a week to clear up.
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Redness and swelling at injection site.
Age: 21.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Anaphylactic reaction, Cough, Dry skin, Pruritus generalised, Rash erythematous
Clinical narrative: Pt came into the immunization clinic to get his H1N1 immunization at 15:25. The patient was screened with the military H1N1 questionnaire and the questions were reviewed by the screener with the patient.  The patient was cleared for the immunization and the immunization was given at 15:28.  At 15:40 the patient started scratching around his neck, face became flushed, started a slight dry cough and bean clearing his throat. Patient then complained of some tightness in his throat, generalized itching, with a generalized no raised erythmic rash noted on his chest and back.  Anaphylaxis protocol started at 15:41 with Epinephrine 1:1000--.3 mgm--IM--LVT. MD notified and was at patient's side within 2 min.  MD examined patient and Benadryl 50 MG given IM LUOQ at 15:45. 15:50--patient given SoluMedrol 125 mg--IM--RUOQ per order.  15:55-patient given Epinepherin 1:100--.3 mgm--IM--RVT.  Patient remained alert, oriented X3. SAO2 remained between 96% to 98%.  Pt. was paced on oxygen via nasal cannula for the first 30 minutes. Pt color remained pink. Skin was warm and dry within 30 minutes.  Rash subsided and patient denied dysphagia, dyspnea after 15 min. of treatment.  Pt. was observed for aprroximately 2 hours and was sent home with a prescription for Predinsone and a return apppointment in 24 hours with Dr.
Age: 21.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Skin warm, Throat irritation, Throat tightness
Clinical narrative: Pt came into the immunization clinic to get his H1N1 immunization at 15:25. The patient was screened with the military H1N1 questionnaire and the questions were reviewed by the screener with the patient.  The patient was cleared for the immunization and the immunization was given at 15:28.  At 15:40 the patient started scratching around his neck, face became flushed, started a slight dry cough and bean clearing his throat. Patient then complained of some tightness in his throat, generalized itching, with a generalized no raised erythmic rash noted on his chest and back.  Anaphylaxis protocol started at 15:41 with Epinephrine 1:1000--.3 mgm--IM--LVT. MD notified and was at patient's side within 2 min.  MD examined patient and Benadryl 50 MG given IM LUOQ at 15:45. 15:50--patient given SoluMedrol 125 mg--IM--RUOQ per order.  15:55-patient given Epinepherin 1:100--.3 mgm--IM--RVT.  Patient remained alert, oriented X3. SAO2 remained between 96% to 98%.  Pt. was paced on oxygen via nasal cannula for the first 30 minutes. Pt color remained pink. Skin was warm and dry within 30 minutes.  Rash subsided and patient denied dysphagia, dyspnea after 15 min. of treatment.  Pt. was observed for aprroximately 2 hours and was sent home with a prescription for Predinsone and a return apppointment in 24 hours with Dr.
Age: 45.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Aphonia, Dysphonia, Foreign body sensation in eyes, Limb discomfort, Ocular hyperaemia
Clinical narrative: The same day in the afternoon I felt pain in the arm where the vaccine was administered (left arm). That night and on Sunday I had discomfort in my eyes (red and feeling of sand). Then on Monday 17 a sore throat started and it worsened in the next 4 days with intermittent fever. By Saturday May 22 I lost my voice (laryngitis). Seven days have gone by and I still have hoarseness and I can barely talk and I still have the discomfort in my arm-when I close my hand it hurts.
Age: 45.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Oropharyngeal pain, Pain, Pain in extremity, Pyrexia
Clinical narrative: The same day in the afternoon I felt pain in the arm where the vaccine was administered (left arm). That night and on Sunday I had discomfort in my eyes (red and feeling of sand). Then on Monday 17 a sore throat started and it worsened in the next 4 days with intermittent fever. By Saturday May 22 I lost my voice (laryngitis). Seven days have gone by and I still have hoarseness and I can barely talk and I still have the discomfort in my arm-when I close my hand it hurts.
Age: 27.0
Sex: M
Vaccine: FLUX(H1N1)
Symptoms: Chills, Fatigue, Headache, Oropharyngeal pain, Pain in extremity
Clinical narrative: Began with fever, headache, later with lower limb pain, fatigue, chills and sore throat.
Age: 27.0
Sex: M
Vaccine: FLUX(H1N1)
Symptoms: Pyrexia
Clinical narrative: Began with fever, headache, later with lower limb pain, fatigue, chills and sore throat.
Age: 0.32
Sex: F
Vaccine: HIBV, PNC13
Symptoms: Crying, Dyspnoea, Muscle twitching
Clinical narrative: Parents state that hours after vaccine administration, pt's crying was different, her breathing was funny, and she made twitching movements.
Age: 3.0
Sex: M
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Right deltoid area red and swollen - deltoid diameter approximately 22.5cm. After 3 doses of Ibuprofen and BENADRYL, redness and swelling almost completely resolved.
Sex: U
Vaccine: DTAPIPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: This case was reported by a healthcare professional, via another manufacturer (Merck) and described the occurrence of injection site redness in a subject of unspecified age and gender who was vaccinated with KINRIX (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of KINRIX (details unknown). Three days after vaccination with KINRIX, the subject experienced injection site redness and swelling injection site. At the time of reporting the outcome of the events was unspecified.
Sex: U
Vaccine: DTAPIPV
Symptoms: Erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: This case was reported by a healthcare professional, via a GSK representative, and described the occurrence of erythema in a subject of unspecified age and gender who was vaccinated with KINRIX, (GlaxoSmithKline).  On an unspecified date the subject received unspecified dose of KINRIX (.5 ml, route unknown).  At an unspecified time after vaccination with KINRIX, the subject experienced erythema, hardness injection site, swelling injection site and injection site warmth.  At the time of reporting the outcome of the events was unspecified.  The healthcare professional considered the events were possibly related to vaccination with KINRIX.  This case corresponds to a pharmaceutical product complaint.  The healthcare professional reported that 15 subjects experienced the same events in the same time period after vaccination with KINRIX.  At the time of reporting, no additional information was available.  This is case 1 or 15 (see case IDs A0860688A, A0860690A - A0860702A for the other reports).
Sex: U
Vaccine: DTAPIPV
Symptoms: Erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: This case was reported by a healthcare professional, via a GSK representative, and described the occurrence of erythema in a subject of unspecified age and gender who was vaccinated with KINRIX, (GlaxoSmithKline).  On an unspecified date the subject received unspecified dose of KINRIX (.5 ml, route unknown).  At an unspecified time after vaccination with KINRIX, the subject experienced erythema, hardness injection site, swelling injection site and injection site warmth.  At the time of reporting the outcome of the events was unspecified.  The healthcare professional considered the events were possibly related to vaccination with KINRIX.  This case corresponds to a pharmaceutical product complaint.  The healthcare professional reported that 15 subjects experienced the same events in the same time period after vaccination with KINRIX.  At the time of reporting, no additional information was available.  This is case 2 of 15 (see case IDs A0860669A, A0860690A - A0860702A for the other reports).
Sex: U
Vaccine: DTAPIPV
Symptoms: Erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: This case was reported by a healthcare professional, via a GSK representative, and described the occurrence of erythema in a subject of unspecified age and gender who was vaccinated with KINRIX, (GlaxoSmithKline).  On an unspecified date the subject received unspecified dose of KINRIX (.5 ml, route unknown).  At an unspecified time after vaccination with KINRIX, the subject experienced erythema, hardness injection site, swelling injection site and injection site warmth.  At the time of reporting the outcome of the events was unspecified.  The healthcare professional considered the events were possibly related to vaccination with KINRIX.  This case corresponds to a pharmaceutical product complaint.  The healthcare professional reported that 15 subjects experienced the same events in the same time period after vaccination with KINRIX.  At the time of reporting, no additional information was available.  This is case 3 of 15 (see case IDs A0860669A, A0860688A, A0860691A - A0860702A for the other reports).
Sex: U
Vaccine: DTAPIPV
Symptoms: Erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: This case was reported by a healthcare professional, via a GSK representative, and described the occurrence of erythema in a subject of unspecified age and gender who was vaccinated with KINRIX (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of KINRIX (.5 ml, route unknown). At an unspecified time after vaccination with KINRIX, the subject experienced erythema, hardness injection site, swelling injection site and injection site warmth. At the time of reporting the outcome of the events was unspecified. The healthcare professional considered the events were possibly related to vaccination with KINRIX. This case corresponds to a pharmaceutical product complaint. The healthcare professional reported that 15 subjects experienced the same events in the same time period after vaccination with KINRIX. At the time of reporting, no additional information was available. This is case 4 of 15 (A0860669A, A0860688A, A0860692A - A0860702A for the other reports).
Sex: U
Vaccine: DTAPIPV
Symptoms: Erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: This case was reported by a healthcare professional, via a GSK representative, and described the occurrence of erythema in a subject of unspecified age and gender who was vaccinated with KINRIX (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of KINRIX (.5 ml, route unknown). At an unspecified time after vaccination with KINRIX, the subject experienced erythema, hardness injection site, swelling injection site and injection site warmth. At the time of reporting the outcome of the events was unspecified. The healthcare professional considered the events were possibly related to vaccination with KINRIX. This case corresponds to a pharmaceutical product complaint. The healthcare professional reported that 15 subjects experienced the same events in the same time period after vaccination with KINRIX. At the time of reporting, no additional information was available. This is case 5 of 15 (see case IDs A0860669A, A0860688A, A0860690A, A0860691A, A0860693A - A0860702A for the other reports).
Sex: U
Vaccine: DTAPIPV
Symptoms: Erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: This case was reported by a healthcare professional, via a GSK representative, and described the occurrence of erythema in a subject of unspecified age and gender who was vaccinated with KINRIX, (GlaxoSmithKline).  On an unspecified date the subject received unspecified dose of KINRIX (.5 ml, route unknown).  At an unspecified time after vaccination with KINRIX, the subject experienced erythema, hardness injection site, swelling injection site and injection site warmth.  At the time of reporting the outcome of the events was unspecified.  The healthcare professional considered the events were possibly related to vaccination with KINRIX.  This case corresponds to a pharmaceutical product complaint.  The healthcare professional reported that 15 subjects experienced the same events in the same time period after vaccination with KINRIX.  At the time of reporting, no additional information was available.  This is case 6 or 15 (see case IDs A0860669A, A0860688A, A0860690A - A0860692A, A0860694A - A0860702A for the other reports).
Sex: U
Vaccine: DTAPIPV
Symptoms: Erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: This case was reported by a healthcare professional, via a GSK representative and described the occurrence of erythema in a subject of unspecified age and gender who was vaccinated with KINRIX, GlaxoSmithKline. On an unspecified date the subject received unspecified dose of KINRIX (.5 ml, route unknown). At an unspecified time after vaccination with KINRIX, the subject experienced erythema, hardness injection site, swelling injection site and injection site warmth. At the time of reporting the outcome of the events was unspecified. The healthcare professional considered the events were possibly related to vaccination with KINRIX. This case corresponds to a pharmaceutical product complaint. The healthcare professional reported that 15 subjects experienced the same events in the same time period after vaccination with KINRIX. At the time of reporting, no additional information was available. This is case 7 of 15 ( see case IDs A0860669A, A0860690A - A0860693A, A0860695A - A0860702A for the other reports).
Sex: U
Vaccine: DTAPIPV
Symptoms: Erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: This case was reported by a healthcare professional, via a GSK representative, and described the occurrence of erythema in a subject of unspecified age and gender who was vaccinated with KINRIX, (GlaxoSmithKline).  On an unspecified date the subject received unspecified dose of KINRIX (.5 ml, route unknown).  At an unspecified time after vaccination with KINRIX, the subject experienced erythema, hardness injection site, swelling injection site and injection site warmth.  At the time of reporting the outcome of the events was unspecified.  The healthcare professional reported that 15 subjects experienced the same events in the same time period after vaccination with KINRIX.  At the time of reporting, no additional information was available.  This is case 8 of 15 (see case IDs A0860669A, A0860688A, A0860690A - A0860694A, A0860696A - A086702A for the other reports).
Sex: U
Vaccine: DTAPIPV
Symptoms: Erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: This case was reported by a healthcare professional, via a GSK representative, and described the occurrence of erythema in a subject of unspecified age nd gender who was vaccinated with KINRIX (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of KINRIX (.5 ml, route unknown). At an unspecified time after vaccination with KINRIX, the subject experienced erythema, hardness injection site, swelling injection site and injection site warmth. At the time of reporting the outcome of the events was unspecified. The healthcare professional considered the events were possibly related to vaccination with KINRIX. This case corresponds to a pharmaceutical product complaint. The healthcare professional reported that 15 subjects experienced the same events in the same time period after vaccination with KINRIX. At the time of reporting, no additional information was available. This is case 9 of 15 (see case IDs A0860669A, A0860688A, A0860690A - A0860695A, A0860697A - A0860702A for other reports).
Sex: U
Vaccine: DTAPIPV
Symptoms: Erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: This case was reported by a healthcare professional, via a GSK representative, and described the occurrence of erythema in a subject of unspecified age and gender who was vaccinated with KINRIX (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of KINRIX (.5 ml, route unknown). At an unspecified time after vaccination with KINRIX, the subject experienced erythema, hardness injection site, swelling injection site and injection site warmth. At the time of reporting the outcome of the events was unspecified. The healthcare professional considered the events were possibly related to vaccination with KINRIX. This case corresponds to a pharmaceutical product complaint. The healthcare professional reported that 15 subjects experienced the same events in the same time period after vaccination with KINRIX. At the time of reporting, no additional information was available. This is case 10 of 15 (see case IDs A0860669A, A0860688A, A0860690A - A0860696A, A0860698A - A0860702A for the other reports).
Sex: U
Vaccine: DTAPIPV
Symptoms: Erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: This case was reported by a healthcare professional, via a GSK representative, and described the occurrence of erythema in a subject of unspecified age and gender who was vaccinated with KINRIX (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of KINRIX (.5 ml, route unknown). At an unspecified time after vaccination with KINRIX, the subject experienced erythema, hardness injection site, swelling injection site and injection site warmth. At the time of reporting the outcome of the events was unspecified. The healthcare professional considered the events were possibly related to vaccination with KINRIX. This case corresponds to a pharmaceutical product complaint. The healthcare professional reported that 15 subjects experienced the same events in the same time period after vaccination with KINRIX. At the time of reporting, no additional information was available. This is case 11 of 15 (see case IDs A0860669A, A0860688A, A0860690A - A0860697A, A0860699A - A0860702A for the other reports).
Sex: U
Vaccine: DTAPIPV
Symptoms: Erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: This case was reported by a healthcare professional, via a GSK representative, and described the occurrence of erythema in a subject of unspecified age and gender who was vaccinated with combined KINRIX, GlaxoSmithKline. On an unspecified date the subject received unspecified dose of KINRIX (.5 ml, route unknown). At an unspecified time after vaccination with KINRIX, the subject experienced erythema, hardness injection site, swelling injection site and injection site warmth. At the time of reporting the outcome of the events was unspecified. The healthcare professional considered the events were probably related to vaccination with KINRIX. This case corresponds to a pharmaceutical product complaint. The healthcare professional reported that 15 subjects experienced the same events in the same time period after vaccination with KINRIX. At the time of reporting, no additional information was available. This is case 12 of 15 (see case IDs A0860669A, A0860688A, A0860690A - A0860698A, A0860700A - A0860702A for the other reports.
Sex: U
Vaccine: DTAPIPV
Symptoms: Erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: This case was reported by a healthcare professional, via a GSK representative, and described the occurrence of erythema in a subject of unspecified age and gender who was vaccinated with combined KINRIX, (GlaxoSmithKline).  On an unspecified date the subject received unspecified dose of KINRIX (.5 ml, route unknown).  At an unspecified time after vaccination with KINRIX, the subject experience erythema, hardness injection site, swelling injection site and injection site warmth.  At the time of reporting the outcome of the events was unspecified.  The healthcare professional considered the events were possibly related to vaccination with KINRIX.  The case corresponds to a pharmaceutical product complaint.  The healthcare professional reported that 15 subjects experienced the same events in the same time period after vaccination with KINRIX.  At the time of reporting, no additional information was available.  This is case 13 of 15 (see case IDs A0860669A, A0860688A, A0860690A - A0860699A, A0860701A, A0860702A for the other reports).
Sex: U
Vaccine: DTAPIPV
Symptoms: Erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: The case was reported by a healthcare professional, via a GSK representative and described the occurrence of erythema in a subject of unspecified age and gender who was vaccinated with KINRIX (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of KINRIX (.5 ml, route unknown). At an unspecified time after vaccination with KINRIX, the subject experienced erythema, hardness injection site, swelling injection site and injection site warmth. At the time of reporting the outcome of the events was unspecified. The healthcare professional considered the events were possibly related to vaccination with KINRIX. This case corresponds to pharmaceutical product complaint. The healthcare professional reported that 15 subjects experienced the same events in the same time period after vaccination with KINRIX. At the time of reporting, no additional information was available. This is case 14 of 15 (see case IDs Ao860669A, A0860688A, A0860690A - A0860700A, A0860702A for the other reports).